ClinicalTrials.gov
public full text
Public Domain
Phenylbutyrate in Proteinuric Nephropathies
The purpose of this study is to determine whether sodium phenylbutyrate can reduce Lcn2 urinary expression in proteinuric patients.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- A Clinical Study of Glycerol Phenylbutyrate in Chinese Patients With Urea Cycle Disorders#854884
- Role of Urine PH in Shock Wave Lithotripsy Outcomes in Renal Stone Disease#846624
- Clinical Trial of Sodium Phenylbutyrate in Children With Spinal Muscular Atrophy Type I#802789
- Efficacy and Safety of SYNB1618 and SYNB1934 in Adult Patients With Phenylketonuria#805613
- First-in-Human, Multiple Part Clinical Study of JNT-517 in Healthy Participants and in Participants With Phenylketonuria#901115
Record · ID 895807
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive